Publicacións en colaboración con investigadores/as de Centre National de la Recherche Scientifique (9)

2020

  1. Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonists

    Neuropharmacology, Vol. 179

2014

  1. Pharmacological properties of novel cyclic pentapeptides with μ-opioid receptor agonist activity

    Medicinal Chemistry, Vol. 10, Núm. 2, pp. 154-161

2012

  1. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands

    Cellular Signalling, Vol. 24, Núm. 3, pp. 699-707

2011

  1. Effect of 2′,6′-dimethyl-l-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 23, pp. 6977-6981

2010

  1. Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2

    Basic and Clinical Pharmacology and Toxicology, Vol. 106, Núm. 2, pp. 106-113

  2. Synthesis and biological evaluation of cyclic endomorphin-2 analogs

    Peptides, Vol. 31, Núm. 2, pp. 339-345

  3. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs

    Peptides, Vol. 31, Núm. 8, pp. 1617-1624

2008

  1. β-homo-amino acid scan of angiotensin IV

    Journal of Medicinal Chemistry, Vol. 51, Núm. 7, pp. 2291-2296

1999

  1. μ-Opioid receptor specific antagonist cyprodime: Characterization by in vitro radioligand and [35S]GTPγS binding assays

    European Journal of Pharmacology, Vol. 383, Núm. 2, pp. 209-214